Clinical Trial Update: Tamoxifen to Treat Barrett's Metaplasia [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study of tamoxifen for Barrett's esophagus (Barrett's metaplasia) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Barrett Metaplasia | EARLY_Phase 1 | Status: TERMINATED